Skip to main content Skip to main navigation menu Skip to site footer

Early detection methods of chronic diabetic nephropathy in diabetes mellitus patients in primary health services

  • Tripitara ,
  • Titiek Hidayati ,
  • Suny Sun ,
  • Akrom ,


Abstract

Introduction: The prevalence of diabetic kidney disease increases along with the increase in the number of patients with diabetes mellitus. Early detection of diabetic nephropathy in DM patients is an essential step in preventing the incidence of diabetic kidney disease. The study aimed to obtain a method of early detection of diabetic kidney disease in DM patients in primary health care via identifying factors associated with decreased glomerular filtration rate (GFR).

Methods: We conducted a case-controlled study at the public health center in Bantul. The research subjects were patients at Kasihan 1 public health center aged 18-75 years. In-depth interviews will be conducted to obtain clinical and social risk factors for GFR decreasing as an early detection tool for diabetic nephropathy (DN) incidence. The IGF-1 levels were checked using ELISA. The Pearson correlation test observed a significant association between patient risk factors and GFR.

Results: This study is expected to obtain a model of the method of early detection of chronic diabetic kidney disease in diabetes mellitus patients in primary health services. The results showed that the GFR was related to systolic blood pressure, diastolic blood pressure, hyperglycemia, nicotine levels, and IGF-1 levels (P<0.00). Increased nicotine levels, increased blood pressure, hyperglycemia, and decreased levels of IGF-1 are associated with decreased GFR. Identifying factors related to the glomerular filtration rate can be used to predict impaired renal function.

Conclusion: Reduced glomerular filtration rates are linked to higher nicotine levels, higher blood pressure, hyperglycemia, and lower IGF-1 levels.

Keywords: Diabetic nephropathy Early detection tool IGF-1 level nicotine level

References

  1. Mihardja L, Delima D, Massie RGA, Karyana M, Nugroho P, Yunir E. Prevalence of kidney dysfunction in diabetes mellitus and associated risk factors among productive age Indonesian. J Diabetes Metab Disord. 2018;17(1):53–61.
  2. de Kort S, Simons CCJM, van den Brandt PA, Janssen-Heijnen MLG, Sanduleanu S, Masclee AAM, et al. Diabetes mellitus, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk. Int J Cancer. 2019;145(7):1774–81.
  3. Xia J, Wang L, Ma Z, Zhong L, Wang Y, Gao Y, et al. Cigarette smoking and chronic kidney disease in the general population: A systematic review and meta-analysis of prospective cohort studies. Nephrol Dial Transplant. 2017;32(3):475–87.
  4. Trihono PP, Rhodia L, Karyanti MR. Kidney Disease Profiles Among Adolescents In Indonesia. Acta Med Indones. 2018;50(4):283–90.
  5. Crosby A, Dunn JL, Aditjondro E, Rachfiansyah. Tobacco Control Is a Wicked Problem: Situating Design Responses in Yogyakarta and Banjarmasin. She Ji J Des Econ Innov. 2019;5(4):261–84. Available from: https://www.sciencedirect.com/science/article/pii/S2405872619300930
  6. Xi B, Liang Y, Liu Y, Yan Y, Zhao M, Ma C, et al. Tobacco use and second-hand smoke exposure in young adolescents aged 12-15 years: data from 68 low-income and middle-income countries. Lancet Glob Heal. 2016;4(11):e795–805. Available from: http://dx.doi.org/10.1016/S2214-109X(16)30187-5
  7. Rokoff LB, Rifas-Shiman SL, Coull BA, Cardenas A, Calafat AM, Ye X, et al. Cumulative exposure to environmental pollutants during early pregnancy and reduced fetal growth: the Project Viva cohort. Environ Health. 2018;17(1):19.
  8. Wang JZ, Zhang RY, Bai J. An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients. Int J Cardiol. 2020;312:137–8. Available from: https://doi.org/10.1016/j.ijcard.2020.04.009
  9. Oh Y. The insulin-like growth factor system in chronic kidney disease: Pathophysiology and therapeutic opportunities. Kidney Res Clin Pract. 2012;31(1):26–37.
  10. Kumar N, Janmohamed K, Jiang J, Ainooson J, Billings A, Chen GQ, et al. Tobacco cessation in low- to middle-income countries: A scoping review of randomized controlled trials. Addict Behav. 2021;112:106612. Available from: https://www.sciencedirect.com/science/article/pii/S0306460320307425
  11. Jhee JH, Joo YS, Kee YK, Jung SY, Park S, Yoon CY, et al. Secondhand smoke and CKD. Clin J Am Soc Nephrol. 2019;14(4):515–22.
  12. Lawson J, Elliott J, Wheeler-Jones C, Syme H, Jepson R. Renal fibrosis in feline chronic kidney disease: Known mediators and mechanisms of injury. Vet J. 2015;203(1):18–26. Available from: http://dx.doi.org/10.1016/j.tvjl.2014.10.009
  13. Lan X, Lederman R, Eng JM, Shoshtari SSM, Saleem MA, Malhotra A, et al. Nicotine Induces Podocyte Apoptosis through Increasing Oxidative Stress. PLoS One. 2016;11(12):e0167071. Available from: https://doi.org/10.1371/journal.pone.0167071
  14. Middlekauff HR, Park J, Moheimani RS. Adverse effects of cigarette and noncigarette smoke exposure on the autonomic nervous system: Mechanisms and implications for cardiovascular risk. J Am Coll Cardiol. 2014;64(16):1740–50. Available from: http://dx.doi.org/10.1016/j.jacc.2014.06.1201
  15. Cedillo-Couvert E, Ricardo AC. Smoking, Vascular Events, and ESRD in Patients With CKD. Am J Kidney Dis. 2016;68(3):338–40. Available from: http://dx.doi.org/10.1053/j.ajkd.2016.06.004
  16. Martínez GJ, Celermajer DS, Patel S. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. Atherosclerosis. 2018;269:262–71. Available from: https://doi.org/10.1016/j.atherosclerosis.2017.12.027
  17. Fu Q, Colgan SP, Shelley CS. Hypoxia: The Force that Drives Chronic Kidney Disease. Clin Med Res. 2016;14(1):15–39.
  18. Rahmani J, Montesanto A, Giovannucci E, Zand H, Barati M, Kopchick JJ, et al. Association between IGF‐1 levels ranges and all‐cause mortality: A meta‐analysis. Aging Cell. 2022;21(2):e13540. Available from: https://onlinelibrary.wiley.com/doi/10.1111/acel.13540
  19. Clemmons DR, Robinson ICAF, Christen Y. IGFs : local repair and survival factors throughout life span. Springer. Springe; 2010.
  20. Dobrucki LW, Tsutsumi Y, Kalinowski L, Dean J, Gavin M, Sen S, et al. Analysis of angiogenesis induced by local IGF-1 expression after myocardial infarction using microSPECT-CT imaging. J Mol Cell Cardiol. 2010;48(6):1071–9. Available from: https://doi.org/10.1016/j.yjmcc.2009.10.008
  21. Bhujade R, Mishra BN, Ibrahim T, Sinha A, Chouhan DS. Can Sever Acute Malnourished children be effectively rehabilitated physically, biochemically and developmentally at nutritional rehabilitation centers: A follow up study from Ujjain. J Fam Med Prim care. 2021;10(1):343–9.
  22. AsghariHanjani N, Vafa MR. The role of IGF-1 in obesity, cardiovascular disease, and cancer. Med J Islam Repub Iran. 2019;33:56.

How to Cite

Tripitara, Titiek Hidayati, Suny Sun, & Akrom. (2023). Early detection methods of chronic diabetic nephropathy in diabetes mellitus patients in primary health services. Bali Medical Journal, 12(1), 530–533. https://doi.org/10.15562/bmj.v12i1.3740
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
4

Total
0

Share